Search Page

1

Cite

Share

Peripheral dopamine receptors, potential targets for a new class of antihypertensive agents. Part I: Subclassification and functional description.

Cavero I, Massingham R, Lefèvre-Borg F. Cavero I, et al. Among authors: lefevre borg f. Life Sci. 1982 Sep 6;31(10):939-48. doi: 10.1016/0024-3205(82)90165-5. Life Sci. 1982. PMID: 6752615 Review.

Cite

Share

2

Cite

Share

Synthesis and analgesic activities of some (4-substituted phenyl-1-piperazinyl)alkyl 2-aminobenzoates and 2-aminonicotinates.

Manoury PM, Dumas AP, Najer H, Branceni D, Prouteau M, Lefevre-Borg FM. Manoury PM, et al. Among authors: lefevre borg fm. J Med Chem. 1979 May;22(5):554-9. doi: 10.1021/jm00191a017. J Med Chem. 1979. PMID: 458805

Cite

Share

3

Cite

Share

Preliminary studies on SL 75212, a new potent cardioselective beta-adrenoceptor antagonist [proceedings].

Boudot JP, Cavero I, Fénard S, Lefèvre-Borg F, Manoury P, Roach AG. Boudot JP, et al. Among authors: lefevre borg f. Br J Pharmacol. 1979 Jul;66(3):445P. Br J Pharmacol. 1979. PMID: 43176 Free PMC article. No abstract available.

Cite

Share

4

Cite

Share

Alfuzosin, a selective alpha 1-adrenoceptor antagonist in the lower urinary tract.

Lefèvre-Borg F, O'Connor SE, Schoemaker H, Hicks PE, Lechaire J, Gautier E, Pierre F, Pimoule C, Manoury P, Langer SZ. Lefèvre-Borg F, et al. Br J Pharmacol. 1993 Aug;109(4):1282-9. doi: 10.1111/j.1476-5381.1993.tb13762.x. Br J Pharmacol. 1993. PMID: 8104650 Free PMC article.

Cite

Share

5

Cite

Share

Mechanism of antihypertensive activity of orally administered prazosin in spontaneously hypertensive rats.

Lefèvre-Borg F, Roach AG, Gomeni R, Cavero I. Lefèvre-Borg F, et al. J Cardiovasc Pharmacol. 1979 Jan-Feb;1(1):31-42. doi: 10.1097/00005344-197901000-00004. J Cardiovasc Pharmacol. 1979. PMID: 94380

Cite

Share

6

Cite

Share

Stimulation of peripheral dopamine receptors in rats: a mechanism for novel antihypertensive agents.

Lefèvre-Borg F, Cavero I. Lefèvre-Borg F, et al. Clin Sci (Lond). 1980 Dec;59 Suppl 6:291s-294s. doi: 10.1042/cs059291s. Clin Sci (Lond). 1980. PMID: 7449273

Cite

Share

7

Cite

Share

Urethane inhibits cardiovascular responses mediated by the stimulation of alpha-2 adrenoceptors in the rat.

Armstrong JM, Lefèvre-Borg F, Scatton B, Cavero I. Armstrong JM, et al. Among authors: lefevre borg f. J Pharmacol Exp Ther. 1982 Nov;223(2):524-35. J Pharmacol Exp Ther. 1982. PMID: 6127404

Cite

Share

8

Cite

Share

Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.

Hicks PE, Cavero I, Manoury P, Lefevre-Borg F, Langer SZ. Hicks PE, et al. Among authors: lefevre borg f. J Pharmacol Exp Ther. 1987 Sep;242(3):1025-34. J Pharmacol Exp Ther. 1987. PMID: 2888869

Cite

Share

9

Cite

Share

Synthesis of a series of compounds related to betaxolol, a new beta 1-adrenoceptor antagonist with a pharmacological and pharmacokinetic profile optimized for the treatment of chronic cardiovascular diseases.

Manoury PM, Binet JL, Rousseau J, Lefèvre-Borg F, Cavero IG. Manoury PM, et al. Among authors: lefevre borg f. J Med Chem. 1987 Jun;30(6):1003-11. doi: 10.1021/jm00389a008. J Med Chem. 1987. PMID: 2884312

Cite

Share

10

Cite

Share

Effects of mianserin, desipramine and maprotiline on blood pressure responses evoked by acetylcholine, histamine and 5-hydroxytryptamine in rats.

Cavero I, Lefèvre-Borg F, Roach AG. Cavero I, et al. Among authors: lefevre borg f. Br J Pharmacol. 1981 Sep;74(1):143-8. doi: 10.1111/j.1476-5381.1981.tb09966.x. Br J Pharmacol. 1981. PMID: 6115693 Free PMC article.

Cite

Share